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Abstract
Salmonella enterica serovar Typhimurium is a Gram-negative bacterial pathogen causing gastroenteritis in humans and a
systemic typhoid-like illness in mice. The capacity of Salmonella to cause diseases relies on the establishment of its
intracellular replication niche, a membrane-bound compartment named the Salmonella-containing vacuole (SCV). This
requires the translocation of bacterial effector proteins into the host cell by type three secretion systems. Among these
effectors, SifA is required for the SCV stability, the formation of Salmonella-induced filaments (SIFs) and plays an important
role in the virulence of Salmonella. Here we show that the effector SopD2 is responsible for the SCV instability that triggers
the cytoplasmic release of a sifA
2 mutant. Deletion of sopD2 also rescued intra-macrophagic replication and increased
virulence of sifA
2 mutants in mice. Membrane tubular structures that extend from the SCV are the hallmark of Salmonella-
infected cells. Until now, these unique structures have not been observed in the absence of SifA. The deletion of sopD2 in a
sifA
2 mutant strain re-established membrane trafficking from the SCV and led to the formation of new membrane tubular
structures, the formation of which is dependent on other Salmonella effector(s). Taken together, our data demonstrate that
SopD2 inhibits the vesicular transport and the formation of tubules that extend outward from the SCV and thereby
contributes to the sifA
2 associated phenotypes. These results also highlight the antagonistic roles played by SopD2 and SifA
in the membrane dynamics of the vacuole, and the complex actions of SopD2, SifA, PipB2 and other unidentified effector(s)
in the biogenesis and maintenance of the Salmonella replicative niche.
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Introduction
The virulence of Salmonella enterica serovar Typhimurium
requires its intracellular replication within a membrane-bound
compartment called the Salmonella-containing vacuole (SCV). This
is achieved by the expression of a Type 3 Secretion System (T3SS-
2) encoded by the Salmonella Pathogenicity Island 2 (SPI-2) that
enables Salmonella to translocate bacterial effectors into the infected
cell [1,2,3,4,5,6]. More than 20 T3SS-2 effectors have been
identified so far, but their molecular activities remain largely
unknown [7]. Some of these T3SS-2 effectors display enzymatic
activities [8,9,10,11,12] or target host proteins [13,14].
The T3SS-2 effector SifA is required for the stability of the SCV
membrane [15]. The vacuolar membrane instability results in the
gradual release of sifA
2 bacteria into the host cytosplasm. As
Salmonella is unable to replicate in macrophage cytosol [15,16], this
mutant presents a strong virulence defect in mice [15,17].
Salmonella-infected cells are characterized by the presence of
membrane tubules enriched in late endosomal markers, known as
Salmonella-induced filaments (SIFs) [17,18]. In addition, a recent
study by Mota et al. shows that Salmonella recruits membrane from
a TGN-derived Scamp3-containing pathway to induce the
formation of Scamp3-positive tubules, comprising the SIFs and
the Salmonella-Induced Scamp3 Tubules (SISTs) [19]. While SISTs
are devoid of late endocytic markers, SIFs are positive for both late
endocytic markers and Scamp3 [19]. Both SIFs and SISTs require
SifA for their development.
Upon translocation, SifAand the T3SS-2 effector PipB2 localize to
the cytosolic face of the SCV and recruit the mammalian proteins
SKIP and kinesin-1, respectively [13,14]. By interacting with kinesin-
1 [13], SKIP promotes the transport of SCV-derived vesicles towards
the cell periphery [20]. A sifA
2 mutant is unable to recruit SKIP and
is thereforedefective in the transport of thesemembrane vesicles [21].
As a consequence, a sifA
2 SCV accumulates high levels of kinesin-1
[13]. The disruption of the sifA
2vacuolar membrane isnot due to the
PipB2-mediated accumulation of kinesin-1 [14,22] but requires the
lipase activity of the T3SS-2 effector SseJ [23]. A sifA
2sseJ
2 strain
resides in a stable vacuole but displays the same intracellular
replication defect as a sifA
2 mutant [24]. In this paper, we show that
deletion of sopD2 in a sifA
2 mutant stabilizes the SCV and restores
intra-macrophagic replication and virulence. It induces the formation
of LAMP1- and Scamp3-negative membrane tubules, which
constitute a so far undescribed tubular network that forms
independently of SIFs and SISTs.
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A sifA
2sopD2
2 mutant strain resides in a stable SCV
AsifA
2mutant is progressivelyreleased into the host cell cytoplasm
whereas an ssaV
2 strain is enclosed in a stable vacuole [15]. This
suggests that T3SS-2 effectors are responsible for the vacuole
instability in the absence of SifA. We confirmed this hypothesis
[15] using a sifA
2ssaV
2 mutant whose vacuole stayed intact (Fig. 1A).
In order to identify the T3SS-2 effector(s) involved in the instability of
the sifA
2 SCV, we tested individually the effect of their deletion in a
sifA
2 mutant strain. HeLa cells were infected with wild-type or
mutant bacteria and the percentage of bacteria enclosed in LAMP1-
positive vacuoles was determined. Most of the mutants behaved
similarly to a sifA
2 strain in terms of SCV stability (Fig. 1A). In
agreement with previous reports [23,24], a sifA
2sseJ
2 SCV was more
stablethan a sifA
2 SCV. Remarkably, the deletion of sopD2 ina sifA
2
strain also significantly increased the percentage of bacteria present in
SCVs. We noticed a modest but constant effect on SCV stability
upon deletion of pipB2 and found a more pronounced effect upon
deletion of sopD2 in a sifA
2pipB2
2 strain (Fig. 1A). The complemen-
tation of sifA
2sopD2
2 and sifA
2sopD2
2pipB2
2 strains with a plasmid
for the expression of SopD2 reduced the percentage of bacteria in
SCV(Fig.1A).Weobservedasimilarcomplementationusinga2HA-
tagged version of SopD2 (data not shown), indicating that both native
and 2HA-tagged proteins were functional. We localized SopD2 in
infected HeLa cells. We found SopD2 on SCVs, SIFs and
cytoplasmic vesicles in cells infected with wild-type Salmonella but its
localisation was exclusively restricted to the SCV in absence of SifA
(Fig. 1B). These results indicate that SopD2 is present on the sifA
2
SCV and that it plays a role in the membrane instability of this
bacterial compartment.
Confocal microscopic observations of infected HeLa cells
revealed that wild-type SCVs contained a single bacterium while
the sifA
2sseJ
2 mutant formed micro-colonies of 2 to 6 bacteria
(Fig. 2). The sifA
2sopD2
2 mutant was present either in wild-type-
like SCVs or in large vacuoles containing several bacteria and
LAMP1 inclusions. sifA
2sopD2
2pipB2
2 vacuoles containing a
single bacterium were rarely found and rather contained several
bacteria with large inclusions of LAMP1 (Fig. 2). An electron
microscopy (EM) qualitative and quantitative analysis was
undertaken to better characterize both the vacuoles and the
ultrastructural appearance of the bacteria within these compart-
ments. Bone marrow-derived mouse macrophages (BMDMs)
infected with the different Salmonella strains were fixed and
processed for EM. Bacteria were observed in three types of
compartments, namely normal SCVs (Fig. 3A), phagolysosomes
(Fig. 3B) and autophagic vacuoles (Fig. 3C). The diverse types of
vacuole were indistinguishable between strains but the percentages
of bacteria within these different compartments or in the cytosol
were different as shown by the scores at 12 hr post-invasion (p.i.)
(Fig. 3D). As expected, over 75% of the WT and 60% of the
sopD2
2 bacteria were confined to SCVs that usually contained a
single bacterium, while at least 50% of the sifA
2 mutant had
escaped the SCV. Deletion of sopD2 in a sifA
2 or sifA
2pipB2
2 strain
considerably reduced the number of cytosolic bacteria. However,
while about 50% of the sifA
2sopD2
2 bacteria resided in normal
SCVs, the sifA
2sopD2
2pipB2
2 mutant was predominantly found in
autophagic vacuoles. The latter usually contained several bacteria
that were mostly morphologically intact. Finally, and for all strains,
about 15 to 30% of the bacteria were enclosed in phagolysosomes.
Bacteria were either morphologically intact as in Figure 3B (30 to
70% depending on strains) or undergoing degradation. All in all,
the EM observations of infected BMDM confirmed that the
deletion of sopD2 in a sifA
2 mutant stabilizes the SCV and showed
that the additional deletion of pipB2 increases significantly the
proportion of vacuoles of autophagic nature.
Characterization of the sifA
2sopD2
2 and
sifA
2sopD2
2pipB2
2 vacuoles
Since some of the mutants resided in autophagic vacuoles in
BMDMs, we asked whether vacuoles previously observed in HeLa
cells were also of an autophagic nature. To address this issue, we
analysed by immunofluorescence the recruitment of different
markers to the SCVs: i) the FK2 antibody that detects both mono-
and poly-ubiquitinylated proteins, ii) P62, also known as
sequestosome-1 (SQSTM1), that links ubiquitinated proteins to
the autophagic machinery [25,26], iii) LC3 that binds directly P62
and is a marker for membranes that are undergoing autophagy
[27]. While little or no wild-type, sifA
2 or sopD2
2 SCVs were
positive for these markers, around 20% of sifA
2sopD2
2 or
sifA
2sopD2
2pipB2
2 SCVs were ubiquitinylated and positive for
P62 and LC3 (Fig. 4A and B). The phenotypes displayed by
sifA
2sopD2
2 and sifA
2sopD2
2pipB2
2 mutants were complemented
when a plasmid for the expression of SopD2 was introduced in the
corresponding mutants (Fig. 4A).
To investigate whether sifA
2sopD2
2 and sifA
2sopD2
2pipB2
2
mutants sequestered in the FK2/P62/LC3-positive vacuoles were
viable or undergoing degradation, we analysed their metabolic
activity using strains that expressed DsRed fluorescence under the
control of an arabinose-inducible promoter. HeLa cells were
infected and DsRed expression was induced at 14 h p.i. for 4 h
before fixing the cells. All the bacteria within P62/LC3-positive
vacuoles expressed DsRed (data not shown). Altogether, these results
indicate that deletion of sopD2 in sifA
2 or sifA
2pipB2
2 mutants
stabilizes the SCV membrane, which is in 20% of the cases
positive for autophagic markers in HeLa cells. The bacteria
contained in these vacuoles did not seem to be degraded, as they
were still metabolically active at late times post-infection.
Deletion of sopD2 in a sifA
2 mutant restores several wild-
type phenotypes
Given the above data and since Salmonella is unable to replicate
in the macrophage cytosol [16] we asked whether deletion of sopD2
Author Summary
Salmonella typhimurium is a bacterial pathogen that
causes diseases ranging from gastroenteritis to typhoid
fever. This bacterium survives inside eukaryotic cells within
a membrane-bound compartment, namely the Salmonella-
containing vacuole. Salmonella injects proteins, named
effectors, into the infected cell. These effectors change the
biology of the infected cell and collectively support
Salmonella replication and virulence. The effector SifA
plays a key role in the bacterial vacuole stability and in the
formation of membrane tubules that extend from the
vacuole. Absence of SifA leads to the disruption of the
vacuolar membrane and, therefore to the release of
bacteria in the cytosolic compartment. Consequently, this
mutant presents significant replication and virulence
defects. Here, we show that an additional Salmonella
effector, SopD2, is responsible for the membrane instabil-
ity of the sifA
2 vacuole. In addition, we demonstrate that
SopD2 acts as an inhibitor of vesicle transport from the
vacuole and that it down-modulates the formation of
tubular structures. These findings describe a role for SopD2
as an antagonist of SifA in terms of vacuolar membrane
dynamics.
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264.7 mouse macrophages were infected with wild-type or mutant
bacteria and the fold increase of intracellular bacteria between 2
and 16 h after phagocytic uptake was determined (Fig. 5A). As
expected [15], a sifA
2 mutant had a strong replication defect and a
sifA
2sseJ
2 mutant [24] did not replicate better than a sifA
2
Figure 1. SopD2 localizes on and destabilizes sifA
2 SCVs. (A) HeLa cells were infected with various GFP-expressing Salmonella strains, fixed
and immunostained for the SCV marker LAMP1. The percentages of bacteria in vacuoles were scored at 10 and 16 h p.i.. Values are means 6 SD of 3
independent experiments. P-values: **, P,0.01; ***, P,0.001. (B) Cells were infected with wild-type (WT) or sifA
2 mutant strains expressing a 2HA-
tagged version of SopD2 and imaged by confocal microscopy for GFP (blue), LAMP1 (green) and SopD2-2HA (red). Magnified insets showing single
LAMP1 or SopD2-2HA labellings are presented in the lower panel. SopD2 localized on wild-type vacuoles and SIFs (arrows) but was solely present on
SCVs in cells infected with a sifA
2 mutant (arrowhead). Scale bar, 10 mm.
doi:10.1371/journal.ppat.1001002.g001
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sopD2 was not impaired in intracellular replication (Fig. 5A).
Deletion of pipB2 in a sifA
2 mutant had no effect on bacterial
replication (Fig. 5A) [14]. However, deletion of sopD2 in both sifA
2
and sifA
2pipB2
2 mutants promoted bacterial replication. Expres-
sion of SopD2 from a plasmid reduced replication of the
sifA
2sopD2
2 and sifA
2sopD2
2pipB2
2 mutant strains (Fig. 5A).
Next, we tested the virulence of these Salmonella mutants in vivo
by performing mixed infections in C57BL/6 mice [29]. We found
that sifA
2 and sifA
2sseJ
2 mutant strains exhibited similar virulence
(COI=1.260.9) (Fig. 5B) while the sifA
2sopD2
2 strain was slightly
but significantly more virulent that the sifA
2 mutant
(COI=2.660.9) (Fig. 5B). Since deletion of pipB2 increases
moderately the virulence of a sifA
2 mutant [14] and since deletion
of sopD2 and pipB2 had an additive effect on the vacuole stability
(Fig. 1A), we also tested a sifA
2sopD2
2pipB2
2 mutant. The
virulence of this mutant was highly increased (COI=7.3563.8).
Deletion of pipB that encodes a PipB2 homolog did not
significantly change the virulence of a sifA
2sopD2
2 mutant.
Compared to the wild-type strain, the sifA
2sopD2
2pipB2
2 mutant
exhibited only a modest attenuation (CI of 0.6360.27), while our
previous data showed a CI of about 0.1 for a sifA
2 mutant [14].
These results indicate that the stabilisation of the sifA
2sseJ
2
vacuole is not sufficient to increase the virulence. They also
indicate that pipB2 and sopD2 contribute independently to the
virulence attenuation of a sifA
2 mutant.
SopD2 contributes to kinesin-1 retention on the sifA
2
vacuole
PipB2 operates as a linker for kinesin-1 on the SCV [14] and the
sifA
2 vacuole is characterized by a high accumulation of this
microtubule motor [13]. In order to define whether SopD2 plays a
role in this process, we scored the percentage of SCVs positive for
kinesin-1 in infected HeLa cells. In agreement with former studies
[13,14], most of the sifA
2 SCVs accumulated kinesin and this
recruitment was completely abrogated upon deletion of pipB2 but
not pipB (Fig. 6A). Deletion of sopD2 in a sifA
2 mutant significantly
decreased the percentage of kinesin-1-positive SCVs, although not
to the same extent as the deletion of pipB2. This deficit was
complemented when a plasmid for the expression of SopD2 was
introduced in the sifA
2sopD2
2 mutant, thus confirming the
specificity of this observation. We also observed and quantified
that deletion of sopD2 in a sifA
2 mutant reduced the vacuolar
membrane load in kinesin-1 (Fig. 6B and C). These findings show
that SopD2 increases both the percentage of vacuoles positive for
kinesin-1 and the amount of kinesin-1 present on sifA
2 vacuoles.
SopD2 inhibits the peripheral transport of kinesin-1-
positive vesicles
Since we observed removal of a significant amount of kinesin-1
upon deletion of sopD2 in a sifA
2 mutant, we asked whether it
could result from the restoration of a vesicular transport from the
SCV. To address this point, we infected HeLa cells with Salmonella
strains expressing 2HA-tagged PipB2 from a plasmid. Consistent
with the previous studies [20,22], we observed the presence of
PipB2/kinesin-1-positive vesicles at the periphery of cells infected
with wild-type Salmonella, while these molecules accumulated on
sifA
2 SCVs and also on sifA
2sseJ
2 SCVs (Fig. 7A). Strikingly, we
observed vesicles positive for both kinesin-1 and PipB2 at the
periphery of HeLa cells (Fig. 7A) and RAW 264.7 macrophages
(data not shown) infected with a sifA
2sopD2
2 mutant, thus giving
images very similar to cells infected with wild-type Salmonella.
These results clearly indicate that, in contrast to SseJ, SopD2
Figure 2. Immunofluorescence imaging of vacuoles enclosing
various Salmonella strains. HeLa cells infected for 16 hours with GFP-
expressing Salmonella strains were immunostained for the SCV marker
LAMP1 and imaged by confocal microscopy for GFP (green) and LAMP1
(red). Insets illustrate the absence of vacuole enclosing sifA
2 bacteria
and the shapes of sifA
2sseJ
2, sifA
2sopD2
2 and sifA
2sopD2
2pipB2
2
vacuoles magnified twice. SIFs (arrows) were only seen in wild-type-
infected cells. Scale bar, 10 mmo r5mm for insets.
doi:10.1371/journal.ppat.1001002.g002
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positive vesicles from sifA
2 SCVs.
SopD2 regulates the formation of T3SS-2 effector-
positive tubules
To gain better insights into the genesis of PipB2/kinesin-1-positive
vesicles, and to avoid the over-expression of PipB2-2HA, we
engineered Salmonella strains expressing PipB2-2HA from the
chromosome. We observed that in HeLa cells PipB2 localized on
sifA
2 SCVs and, very surprisingly, on the sifA
2sopD2
2 SCVs and
tubular structures that extended from the vacuole (Fig. 7B). These
tubular structures are reminiscent of SIFs. Therefore we examined
whether SIFs, which are LAMP1-positive tubular structures [18] and
which have never been observed in the absence of SifA, were formed
in concomitant absence of SifA and SopD2. Most tubular structures
were positive for both LAMP1 and PipB2 in cells infected with wild-
type Salmonella, while tubules formed in cells infected with the
sifA
2sopD2
2 mutant were negative for LAMP1 (Fig. 7B). In
agreement with a previous report [30], a discontinuous distribution
of LAMP1 along effector-positive tubule and also LAMP1-negative
tubules (Fig 7B) were observed in the sole absence of SopD2.
Strains expressing SseJ-2HA from the chromosome were used
to score the occurrence of these membranous tubular structures.
SIFs (LAMP1-positive tubules) were present in nearly 65 and 45%
of cells infected with wild-type and sopD2
2 strains, respectively,
while SseJ-positive tubules were seen in about 80% of cells infected
with either strain (Fig. 8A). In agreement with previous data
[17,31], neither SIFs nor effector-positive tubules were detected in
cells infected with a sifA
2 mutant. SseJ-positive tubules were
formed in 55% of cells infected with sifA
2sopD2
2 mutant, while
SIFs were barely detected. A sifA
2sopD2
2 strain is therefore able to
form T3SS-2 effector-positive and LAMP1-negative structures
that are hereafter referred to as LNT for LAMP1-Negative
Tubule. We scored LNTs in cells infected with strains expressing
either 2HA-tagged PipB2 or SseJ from the chromosome and very
similar results were obtained (Fig. 8B). LNTs were more frequently
found in cells infected with a sopD2
2 mutant than with wild-type
Salmonella. Since PipB2 is involved in the centrifugal extension of
SIFs [32], we tested whether this effector was involved in the
formation of LNTs. A sifA
2sopD2
2pipB2
2 strain was still able to
form effector-positive tubules (Fig. 6C and D). However these
tubules were much shorter compared to those of the sifA
2sopD2
2
mutant (data not shown), indicating that PipB2 participates to their
elongation. Conversely, the accumulation of peripheral vesicles in
cells infected with Salmonella over-expressing PipB2 (Fig. 7A)
suggests that these vesicles come from the PipB2-mediated
fragmentation of LNTs. All in all, these results indicate that
SopD2 inhibits the formation of LNTs and that SopD2 and SifA
have antagonistic roles regarding their formation, while PipB2 is
involved in their centrifugal extension.
Characterisation of LNTs
To gain more insights into the structure and the kinetics of LNT
formation, we observed and scored both LNTs and SIFs at selected
Figure 3. Morphological appearance of Salmonella vacuoles. BMDMs were infected with various Salmonella strains. At 12 h p.i., cells were
fixed and processed for characterization of the vacuoles. (A–C) Morphological appearance of the various sifA
2sopD2
2pipB2
2 vacuoles. (A) View of a
normal SCV. Lysosomes (Ly) do not fuse with this compartment. (B) A lysosome (Ly) is seen fusing with an SCV to form a phagolysosome (PhLy). In
this PhLy, the bacterium is still morphologically intact. (C) View of an autophagic vacuole (AV). Cytoplasmic material (star) and bacteria can be seeni n
the AV, which also contains dense lysosomal material (arrowhead). Arrows indicate the membrane of the AV. Scale bar: 0.5 mm (A and B), 1,5 mm (C).
(D) The fraction of bacteria enclosed in the different types of compartments as shown in A, B and C or in the cytosol was scored.
doi:10.1371/journal.ppat.1001002.g003
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structures emerging from SCVs and extending towards the cell
periphery. PipB2 localized all along LNTs but presented a patch-like
distribution (Fig. 9A). As we noticed that LNTs were frequently in
contact with LAMP1-positive vesicles, both in wild-type and
sifA
2sopD2
2 infected cells (arrows in Fig. 9B and C), these structures
(LNT in contact with LAMP1 vesicle)were scored separately. Inwild-
type infected cells, the three types of structures appeared simulta-
neously at 3–4 hours p.i.. Then, the occurrence of SIFs increased and
reached a plateau at 8 hours p.i., while the percentage of cells with
LNTs and LNTs in contact with LAMP1-vesicles remained lower
than 20% of infected cells starting from 4 hours p.i. (Fig. 9B and D).
The sifA
2sopD2
2 strain predominantly generated LNTs. The
percentage of LNT contacting LAMP1-vesicles was reduced
compared to cells infected with the wild-type strain, especially at
early times of infection (Fig. 9C and E).
In addition to SIFs, Salmonella induces the formation of SISTs,
which are Scamp3-positive tubules that lack late endosomal/
lysosomal proteins [19]. Therefore, we asked whether LNTs
correspond to SISTs. In wild-type infected cells, Scamp3 was
found on tubules that were frequently positive for PipB2.
Conversely, Scamp3 was distributed in the perinuclear area both
in non-infected (data not shown) and cells infected with the
sifA
2sopD2
2 mutant (Fig. 10A). These results suggest that LNTs
form independently from SISTs.
Finally, we examined LNTs for the presence of other markers and
analyzed their sensitivity to several treatments (Table 1). Unlike SIFs,
LNTs were negative for Rab7, the lysosomal glycoproteins LAMP1,
CD63 and the late endosomal lipid LBPA. Similar to SIFs, LNTs
were positive for the vacuolar ATPase (vATP) and contained
cholesterol. As listed in Table 1, LNTs were negative for most
endocytic and exocytic markers. The host protein SKIP was not
involved in LNT formation. LNTs were found aligned with
microtubules (Fig. 10B) and their extension and maintenance were
dependent on an intact microtubule network. Treatment with
nocodazole at 3h p.i., when LNTs start to form, impaired their
formation. Integrity of the LNTnetwork was affected by disruption of
microtubules at 14h p.i.. Treatment with the actin-disrupting agent
cytochalasin D had any impact on LNT stability or formation. In
contrast to SIST, brefeldin A treatment of infected cells did not
significantly affect LNT formation (Table 1), suggesting that a
functional exocytic pathway is not required. These data confirm that
LNTsand SISTsare distinctstructures. They also indicate that LNTs
are likely to form along microtubules, but are devoid of most markers
associated with SIFs. Together, these results demonstrate the
presence of at least three types of tubules in Salmonella infected cells:
SIFs [18], SISTs [19], and LNTs.
Discussion
In this work, we demonstrate that the T3SS-2 effector SopD2 is
present on the sifA
2 SCV and that it contributes to its membrane
instability. sifA
2sopD2
2 and sifA
2pipB2
2sopD2
2 mutant strains are
enclosed and replicate in steady vacuoles. As previously shown
[23,24], a sifA
2sseJ
2 mutant resides also in a stable vacuole, which,
however, does not support bacterial replication. In addition, in
contrast to sifA
2sopD2
2,asifA
2sseJ
2 strain is not more virulent
than a sifA
2 mutant. Therefore, it appears that a stable vacuole is
necessary but not sufficient for intracellular replication and
virulence in the mouse model.
Figure 4. A fraction of sifA
2sopD2
2 and sifA
2pipB2
2sopD2
2 vacuoles displays autophagic features. HeLa cells were infected for 16 h with
GFP-expressing Salmonella strains, fixed and immunostained for FK2, P62 or LC3 and LAMP1 as a SCV membrane marker. (A) The percentages of FK2-,
P62- or LC3- positive vacuoles were scored. Deletion of sopD2 increased the percentages of vacuoles positives for these markers. These phenotypes
were complemented by expression of sopD2 from a plasmid. Values are means 6 SD of 3 independent experiments. (B) HeLa cells were imaged by
confocal microscopy for GFP (green), LAMP1 (red) and P62 (blue). Scale bar, 5 mm.
doi:10.1371/journal.ppat.1001002.g004
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2 and sifA
2pipB2
2 mutant strains. (A) RAW264.7
macrophages were infected with wild-type and various mutant strains and lysed at 2 and 16 h p.i. for enumeration of intracellular bacteria. The values
shownrepresentthefoldincreasecalculatedasaratiooftheintracellularbacteriabetween16and2 handnormalizedtothatofthewild-typestrain.Values
are means 6 SD(n=6). (B) Both PipB2 and SopD2 impactthe virulenceattenuation of a sifA
2 mutant in the mouse model. Mice were inoculated i.p. with a
mixture of two strains. Two days after infection, spleens were harvested for bacterial counts. COIs of sifA
2sopD2
2 (n=4), sifA
2sopD2
2pipB
2 (n=4),
sifA
2sopD2
2pipB2
2 (n=10), sifA
2sseJ
2 (n=4), against the sifA
2 strain and the CI of sifA
2sopD2
2pipB2
2 against the wild-type (WT) strain (n=6) were
determined. Each symbol represents the COI/CI from one mouse, and horizontal bars correspond to the means 6 SD. A one-sample t test was used to
determine whether the mean value was significantly different from 1. (A and B) P-values: ns, not significant; *, P,0.05; ***, P,0.001.
doi:10.1371/journal.ppat.1001002.g005
Figure 6. SopD2 influences the retention of kinesin-1 on the bacterial vacuole. HeLa cells were infected with various GFP-expressing strains
fixed and immunostained for kinesin heavy chain and LAMP1 as a SCV membrane marker (not shown). (A) Deletion of sopD2 reduces the percentage
of kinesin-1-positive sifA
2 SCVs. Kinesin-1-positive SCVs were scored at 10 and 16 h p.i.. Values are means 6 SD of 3 independent experiments. (B and
C) Deletion of sopD2 decreases the amount of kinesin-1 on sifA
2 SCVs. (B) HeLa cells infected for 16 h were imaged by confocal microscopy for GFP
(green) and kinesin-1 (red). Scale bar, 10 mm. (C) Quantitative analysis of confocal images was used to determine the relative staining intensities for
kinesin-1 of sifA
2 and sifA
2sopD2
2 vacuoles. Each point corresponds to the analysis of one SCV. Results of one experiment are shown. This
experiment was repeated three times, with comparable results. P-values: ** P,0.01; *** P,0.001.
doi:10.1371/journal.ppat.1001002.g006
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sifA
2sopD2
2 and sifA
2pipB2
2sopD2
2 mutant bacteria resides in
autophagosome-like vacuoles in which they remain metabolically
active. This indicates that the harmonized activities of SifA,
SopD2 and PipB2 are necessary for the formation and/or
maintenance of a canonical SCV. It also shows that Salmonella is
Figure 7.SopD2inhibits the formation of effector-positive vesicles andtubules. (A) SopD2blocks theformation of PipB2-and kinesin-1-positive
vesicles. HeLa cells were infected for 16 hours with strains over-expressing PipB2-2HA from a plasmid. Fixed cells were immunostained and imaged for HA
(green), kinesin heavy chain (red) and GFP (blue). Solid and dotted lines (central rows) delineate cells and nuclei, respectively. PipB2- and kinesin-positive
vesicles accumulate at the periphery of cells infected with wild-type and sifA
2sopD2
2 strains while these molecules accumulated on sifA
2 and sifA
2sseJ
2
SCVs. (B) SopD2 negatively regulates the formation of PipB2-positive but LAMP1-negative tubules. HeLa cells were infected with strains (blue) expressing
2HA-tagged PipB2 from the chromosome. Fixed cells were immunostained and imaged for HA (green), LAMP1 (red) and GFP (blue). PipB2- and LAMP1-
positive tubule (arrowheads) and PipB2-postive but LAMP1-negative tubule (arrows) are indicated. (A and B) Scale bar, 20 mm.
doi:10.1371/journal.ppat.1001002.g007
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autophagic pathway. Yet, it remains unclear why a fraction of
SCVs gets ubiquitinylated and recognized by the autophagy
machinery. One possibility is that SopD2 is somehow involved in
the suppression of autophagy, thereby protecting Salmonella from
xenophagy. However, this hypothesis is inconsistent with the fact
that this phenotype was not observed in the sole absence of
SopD2.
SifA and SopD2 have antagonistic activities regarding the
stability of the bacterial vacuole, the intra-macrophagic replication
and the virulence. However, the deletion of sopD2 in a sifA
2
background isnotsufficienttorecovercertainwild-typephenotypes.
Noticeably, a sifA
2sopD2
2 mutant is not able to trigger the
formation of SIFs and SISTs, pointing out to a crucial role for
SifA in the formation of these membranous tubular structures. Also,
a sifA
2sopD2
2 mutant still accumulates kinesin-1, but to a lower
extent than a sifA
2 mutant. This subtle but reproducible change
results from the increased SCV membrane exchange activity, which
in HeLa cells and macrophages infected with a sifA
2sopD2
2 strain
expressing PipB2-2HA from a plasmid, leads to the accumulation of
effector- and kinesin-positive vesicles at the cell periphery. In cells
infected with bacteria expressing physiological levels of this effector,
this leads to the formation of tubules, the LNTs, which extend from
the bacterial vacuole. Our data indicate that SopD2 inhibits the
formation of LNT. Consistently cells infected with a sopD2
2 mutant
exhibit more effector-positive tubules, which were either negative
for LAMP-1 or presented a patchy distribution of this marker.
These tubules have been previously described and named ‘‘pseudo-
SIFs’’ [30]. This observation possibly reflects the activity of SopD2,
which, even in the presence of SifA, restricts the formation of
effector-positive tubules.
Because LNTs do not require SifA nor an intact secretory
pathway for their formation, these tubules are undoubtedly distinct
from SIFs and SISTs. It is unknown which intracellular
compartment LNTs derive from. While SISTs appear to originate
from the secretory pathway, SIFs are composed of both endosomal
and TGN-derived material [18,19,33]. LNTs were found to be
positive for the vATPase but were devoid of all other exocytic and
endocytic markers tested so far. Yet, LNTs are, like SCVs,
enriched in T3SS-2 effectors indicating that they might extend
from the SCV membrane. Strikingly, effector-positive tubules
projecting from the SCV that do not localize with either endocytic
or Golgi markers were recently identified by live-cell imaging [34].
Also, how LNTs are generated remains unknown. Like SIFs and
SISTs [18,19,32,35], their formation is dependent on an intact
microtubule network. We observed that LNTs were shorter in
absence of PipB2, indicating a role for kinesin-1 in the extension of
LNTs along microtubules. Indeed, the accumulation of vesicles
observed in cells infected with a sifA
2sopD2
2 mutant that over-
expresses PipB2 from a plasmid likely reflects a kinesin-mediated
fragmentation of LNT into vesicles.
Interestingly, the presence of LNT was concomitant with an
increased stability of the SCV membrane. This suggests that LNTs
might help recruit and transport membrane towards SCVs.
Microscopic observations revealed that LAMP1-positive vesicles
were occasionally enclosed in T3SS-2 effector-positive tubules.
Indeed, the LNTs seem to wrap around LAMP1 vesicles. The close
apposition between LNTs and vesicles might favour fusion and
transfer of membrane from these vesicles to LNTs and subsequently
to SCVs. This recruitment would ensure a supply in membrane and
promote the stability of the vacuole. We propose that, in the absence
of SifA and SopD2, closeapposition between LNTs and vesicles is not
efficient enough to trigger a massive recruitment of lysosomal
membrane markers to the SCV and tubules but that these contacts
g e n e r a t ear e t r o g r a d ef l o wo fm e m b r a n es u f f i c i e n tt os t a b i l i z et h e
bacterial vacuole. LNTs were not observed in cells infected with a
sifA
2sseJ
2 mutant and sseJ-2HA was even used as marker for LNT.
Thus, the instability of the sifA
2 vacuole results from both the
enzymatic activity of SseJ [23,24] and the inhibition of membrane
exchange activity of SopD2.
Figure 8. Scoring of SIFs and effector-positive tubules in infected HeLa cells. HeLa cells were infected for 16 h with strains expressing SseJ-
2HA or PipB2-2HA from the chromosome. (A) Cells were immunolabelled for LAMP1 and SseJ-2HA. The percentage of infected cells containing
LAMP1- or HA-positive tubules was scored. (B) Cells were immunolabelled for LAMP1 and HA. The percentage of infected cells containing LAMP1-
Negative Tubules (LNTs) was scored. (A and B) Values are means 6 SD of 3 independent experiments.
doi:10.1371/journal.ppat.1001002.g008
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PLoS Pathogens | www.plospathogens.org 9 July 2010 | Volume 6 | Issue 7 | e1001002Figure 9. Structure and kinetics of formation of LNTs. HeLa cells were infected with GFP-expressing wild-type or sifA
2sopD2 strains (blue) and
immunostained for LAMP1 (red) and PipB2-2HA (green) expressed from the chromosome. Images in (A) present a cell infected for 16h with the
sifA
2sopD2
2 mutant strain. The right image is the delineated zone magnified 3 times. LNTs as long as 30–40 mm were observed. Scale bar, 10 mm (left
image) and 3,3 mm (right image). (B to C) Cells were fixed at 4, 6 and 8 h, and imaged. Short LNTs were observed as early 4 h p.i.. LNTs contacting
LAMP1-positive vesicles were frequently observed (arrows in B and C). Scale bar, 10 mm. (D and E) LNTs, LNTs contacting LAMP1-positive vesicles and
SIFs were scored at different time-points. Values are mean 6 SD of 3 independent experiments.
doi:10.1371/journal.ppat.1001002.g009
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of SCV stability and as an inhibitor of LNTs formation. LNTs are
a novel kind of tubules that may represent precursors of SIFs and
SISTs. The formation of LNTs likely involves additional T3SS-2
effectors and our work opens the way for their identification and
characterization. Another interesting challenge will be to under-
stand the cell biology of LNT initiation and the molecular
mechanism by which SopD2 blocks LNT formation.
Materials and Methods
Ethics statement
Animal experimentation was conducted in strict accordance
with good animal practice as defined by the French animal welfare
bodies (Law 87–848 dated 19 October 1987 modified by Decree
2001-464 and Decree 2001-131 relative to European Convention,
EEC Directive 86/609). All animal work was approved by the
Direction De ´partmentale des Services Ve ´te ´rinaires des Bouches du
Rho ˆnes (authorization number 13.118 to S.M.).
Bacterial strains, plasmids, and culture conditions
The S. enterica serovar Typhimurium strains and plasmids used
in this study and their relevant characteristics are listed in Tables 2
and 3. Strains were cultured in LB broth (Difco) at 37uC.
Ampicillin (50 mg/ml), kanamycin (50 mg/ml), and chloramphen-
icol (50 mg/ml) were added when required.
Bacterial mutagenesis
Mutagenesis was carried out by using the gene disruption
method described by Datsenko and Wanner, except that 10 mM
arabinose was used to induce expression of the red recombinase
[36]. The strains expressing PipB2-2HA, SopD2-2HA or SseJ-
2HA from the chromosome were obtained using the method
described by Uzzau and colleagues [37]. The oligonucleotide
primers used to amplify pKD4 kanamycin or pKD3 chloram-
phenicol resistance genes are listed in Table 4. All mutagenesis was
performed in the 12023 wild-type strain. Strains carrying two or
three mutations were created by transduction using the phage P22
HT105 int. Phage-free transductants were selected for analysis.
Gene deletions and transductions were checked by PCR.
Eukaryotic cells and culture conditions
RAW264.7 and HeLa cell lines were grown in DMEM
(GibcoBRL) supplemented with 10% foetal calf serum (FCS;
GibcoBRL), 2 mM nonessential amino acids, and glutamine
(GibcoBRL) at 37uCi n5 %C O 2. Bone marrow cells were isolated
from femurs of 6- to 10-week-old C57BL6 female mice and
differentiated into macrophages as previously described [38].
Bacterial infection and replication assays
HeLa cells were seeded in 6-well plates with or without 12-mm
diameter glass coverslips at a surface ratio of 1/10, 24 h before
Figure 10. Characterization of LNTs. (A) LNTs are negative for Scamp3. Infected HeLa cells were fixed at 16 h p.i., immunolabelled and imaged
for GFP (blue), PipB2-2HA (red) expressed from the chromosome and Scamp3 (green). Scale bar, 20 mm. (B) LNTs (green) are aligned (arrows) along
microtubules (red). Scale bar, 10 mm.
doi:10.1371/journal.ppat.1001002.g010
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diluted 1:33 in fresh LB broth, and incubated in the same
conditions for 3.5 h. The cultures were diluted in Earle’s buffered
salt solution (pH 7.4) and added to the cells at a multiplicity of
infection of 100:1. The infection was allowed to proceed for
10 min at 37uCi n5 %C O 2. Macrophages were seeded at a
density of 10
6 cells per well in 6-well tissue culture plates 24 h
before use. Bacteria were cultured overnight at 37uC with shaking
and were opsonised in DMEM containing FCS and 10% normal
mouse serum for 30 min on ice. Bacteria were added to the cells at
a multiplicity of infection of 100:1. Plates were centrifuged at
500 g for 5 min at 4uC and incubated for 30 min at 37uCi n5 %
CO2. Cells were washed three times with growth medium
containing 100 mg/ml gentamicin and then incubated in this
medium for 1 h, after which the gentamicin concentration was
decreased to 10 mg/ml for the remainder of the experiment. For
enumeration of intracellular bacteria, macrophages were washed
three times with PBS and lysed with 0.1% Triton X-100 for
10 min, and a dilution series was plated onto LB agar plates. Plates
were incubated overnight at 37uC, and colonies were counted.
Each time point was performed in triplicate, and each experiment
was performed three times or more.
RNA interference
10–20% confluent HeLa cells were transfected with RNA
duplexes (Quiagen) previously described [13] using siPORT
Amine transfection agent (Applied Biosystems Ambion) according
to the manufacturer’s instructions. Cells were further incubated for
72 hours.
Drugs and reagents
Brefeldin A (BFA, Sigma), nocodazole (Sigma), cytochalasin D
(Biomol) stock solutions were prepared in dimethyl sulphoxide
(DMSO) and kept at 220uC. Working concentrations were 5 mg/
ml for BFA and 2mg/ml for both nocodazole and cytochalasin D.
Drugs were added on the cells either at 3 h30 or 14 h p.i. for a
further incubation of 4 h or 2 h respectively. Stock solution of
Table 1. Features of LNT, SIF and SIST.
Marker
(compartment)* SIFs SISTs LNTs References
LAMP1 (LE/Lys) + 22[18]
Scamp3 +/2 + 2 [19]
T3SS-2 effector ++ + [15,17,19,23,28,32,40,41,42]
EEA1 2 n.d. 2 [43]
Rab5 (EE) 2 n.d. 2 [33]
Rab7 (LE) + n.d. 2 [33]
Rab9 (LE) 2 n.d. 2
vATPase (LE/Lys) + 2 + [15]
Yip3 (LE) 2 n.d. 2
Syntaxin 7 (LE) n.d. n.d. 2
LBPA (LE) + n.d. 2 [33]
CD63 (LE/Lys) + 22[15]
Mannose 6-Phosphate
Receptor (LE, TGN)
2 n.d. 2 [44,45]
VPS26 (TGN) 2 n.d. 2
Syntaxin 6 (TGN) 2 n.d. 2
P230 (TGN) 2 n.d. 2
GM 130 (cis Golgi) 2 n.d. 2
Calreticulin (ER) 2 n.d. 2
Calnexin (ER) 2 n.d. 2
Dynein (P150
glued) 2 n.d. 2 [13]
Cholesterol + n.d. + [33]
Susceptibility
Nocodazole ++ + [19,35,46]
Cytochalasin D 2 n.d. 2 [35,46]
Brefeldin A 2 + 2 [19,33]
SKIP RNAi + n.d. 2 [13]
EE, early endosome; ER, endoplasmic reticulum; LE, late endosome; LE/Lys, late
endosome/lysosome; TGN, trans-Golgi network.
n.d., not determined.
doi:10.1371/journal.ppat.1001002.t001
Table 2. Salmonella strains used in this study.
Name
Parental
Strain Characteristics Source
12023 12023 wild-type [47]
DH215sc4 12023 sifA
2 [14]
DsopD2 12023 sopD2::cm Junkal Garmendia
and David Holden
DsopD2 12023 sopD2::kan Junkal Garmendia
and David Holden
TH120 12023 sifA::kan, sseF
2 [14]
TH121 12023 sifA
2, srfJ::pGF704 [14]
TH122 12023 sifA
2, sopD2::kan this study
TH123 12023 sifA
2, sseG::kan [14]
TH125 12023 sifA
2, ssaV
2::aphT [14]
TH127 12023 sifA
2,sseI::pGF704 [14]
TH129sc4 12023 sifA
2, sseJ
2 [14]
TH145 12023 sifA
2, pipB::kan [14]
TH146sc4 12023 sifA
2, pipB2
2 [14]
TH150 12023 sifA
2, sopD2::cm [14]
TH153 12023 sifA
2, sopD2::cm, pipB::kan this study
TH154sc 12023 sifA
2, sopD2
2, pipB2
2 this study
NS021 12023 sopD2::kan,psopD2-2HA this study
NS022 12023 sifA
2, sopD2
2, pipB2
2,
psopD2-2HA
this study
NS023 12023 sifA
2, sopD2::kan,
psopD2-2HA
this study
SseJ-2HAchr 12023 sseJ-2HAchr
(chromosomal)
[48]
AAG006 12023 sifA
2, sseJ-2HAchr
(chromosomal)
this study
AAG008 12023 sopD2
2, sseJ-2HAchr this study
AAG013 12023 sifA
2, sopD2
2,
sseJ-2HAchr
this study
AAG017 12023 sifA
2, sopD2
2, pipB2
2,
sseJ-2HAchr
this study
AAG020 12023 pipB2-2HAchr this study
AAG021 12023 sopD2-2HAchr this study
AAG022sc4 12023 sifA
2, pipB2-2HAchr this study
AAG023scs 12023 sopD2
2, pipB2-2HAchr this study
AAG025scs 12023 sifA
2, sopD2
2,
pipB2-2HAchr
this study
doi:10.1371/journal.ppat.1001002.t002
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Bacterial DsRed expression was induced by addition of arabinose
to the cells (0.4%) at 12 h or 14 h post infection and cells
incubated of further 4 h. Filipin (Sigma) stock solution was
prepared in DMSO (25 mg/ml) and stored at 220uC. To label
cellular cholesterol, fixed cells were stained for 2 h with 50 mg/ml
filipin in PBS containing 10% normal foetal bovine serum (FBS,
GibcoBRL).
Immunofluorescence
Cells grown on coverslips were fixed with 3% paraformaldehyde
(pH 7.4) in PBS at room temperature for 10 min. For immuno-
staining of tubulin, cell were further fixed in 80% methanol/1%
paraformaldehyde for 5 min at 220uC. Fixed cells were washed
three times in PBS and permeabilized with 0.1% saponin in PBS.
Primary and secondary antibodies were diluted in PBS containing
0.1% saponin and 5% horse serum. Coverslips were incubated
with primary antibodies for 60 min at room temperature, washed
once in PBS containing 0.1% saponin and then incubated with
appropriate secondary antibodies. Coverslips were mounted onto
glass slides using ProLong Gold (Invitrogen). Cells were observed
with an epifluorescence microscope (Leica) or a LSM510 confocal
laser scanning microscope (Zeiss).
Antibodies
The mouse monoclonal antibodies anti-LAMP1 H4A3 and
anti-CD63 H5C6, developed by J. T. August and J. E. K.
Hildreth, obtained from the Developmental Studies Hybridoma
Bank (DSHB) under the auspiceso ft h eN I C H Da n dm a i n t a i n e d
by the University of Iowa (Department of Biological Sciences,
Iowa, IA), were used at a dilution of 1:1000. The rabbit anti-
LAMP1 was obtained from Dr. Minoru Fukuda (La Jolla
Cancer Research Foundation) was used at a dilution of 1:1000.
The mouse monoclonal antibodies anti-LC3 (clone 5F10;
Nanotools) and FK2 (which detects both mono- and poly-
ubiquitinylated proteins) (Biomol) were used at a dilution of 1:50
and 1:10
4, respectively. The rabbit anti-Sequestosome-1
(SQSTM1, also known as P62) (H-290; Santa Cruz Biotech-
nology) was used at a dilution of 1:100. The rabbit anti-kinesin
HC (KIF5B) antibody PCP42, generously provided by R. Vale
(University of California, San Francisco), was absorbed on
Salmonella acetone powder to remove contaminating anti-
enterobacteria antibodies and used at a dilution of 1:100. The
mouse anti-HA (clone 16B12; Covance, Richmond, CA) and the
rat anti-HA (clone 3F10; Roche) antibodies were used at 1:1000
and 1:200, respectively. The rabbit anti-Scamp3 antibody,
generously provided by J. David Castle (University of Virginia,
Charlottesville) was used at a dilution of 1:250. The sheep anti
human TGN46 antibody (Serotec) was used at a dilution of
1:500. The mouse anti-tubulin (Sigma) was used at a dilution of
1:2000. The mouse anti vATPase monoclonal antibody (OSW2)
was obtained from Dr Satoshi B. Sato (Kyoto University) and
was used at 1:1000. The rabbit anti-Rab7 [39] and the mouse
anti-Rab 5 (D-11, Santa Cruz Biotechnology) were used at a
dilution of 1:200 and 1:100, respectively. The rabbit anti-
calnexin (Stressgen) and the rabbit anti-cathepsin D (Dako) were
used at a dilution of 1:500 and 1:50, respectively. The rabbit
anti-mannose 6-phosphate receptor was a kind gift by Prof.
Bernard Hoflack (University of Dresden) and was used at a
dilution of 1:250. Mouse anti-LBPA, generously provided by
Prof. Jean Gruenberg (University of Geneva), was used at a
dilution of 1:50. The mouse (1E6, Biodesign) and rabbit anti-
Salmonella LPS (Difco Laboratories) antibodies were used at a
concentration of 1:1000 and 1:2000, respectively. Mouse
monoclonal antibody against human MHC class II molecules
(clone L243) was used at 1/10. Secondary antibodies (donkey
anti-rabbit, anti-rat, anti-mouse or anti-sheep IgG conjugated to
FITC, Texas red, or cyanine 5) were purchased from Jackson
ImmunoResearch and used at a dilution of 1:100. The goat
anti-rabbit or anti-mouse IgG conjugated to Alexa Fluor 350
(Molecular Probes) were used at a dilution of 1:1000.
Polymerized actin was stained with Alexa 568-conjugated
phalloidin (Invitrogen).
Table 3. Plasmids used in this study.
Name Characteristics Source
pFVP25.1 Gfpmut3A [49]
pKD3 Chloramphenicol cassette [36]
pKD4 Kanamycin cassette [36]
pKD46 repA101(ts), araBp-gam-bet- exo [36]
pCP20 ts-rep, [FLP] [36]
pDsRed_T3.S4T DsRed Arabinose-inducible D. Bumann
pSopD2-2HA SopD2-2HA in Salmonella This study
pPipB2-2HA PipB2-2HA in Salmonella [22]
doi:10.1371/journal.ppat.1001002.t003
Table 4. Oligonucleotides used in this study.
Oligonucleotides Sequence (59 to 39)
SopD2 chromosomal 2-HA tag O-417 TTTATTTATAAGTGAAAAGTCGAGTTGTCGCAATATGCTTATATATCCGTACGATG-
TACCTGACTATGCATATCCGTACGATGTTCCAGACTATGCTTGAGTGTAGGCTGGAGCTGCTTC
SopD2 chr 2-HA tag O-114 AAAAGCGTACAAAAAAGGCTCCATATCAGTGGGGCCCATATGAATATCCTCCTTAG
PipB2 chr 2-HA tag O-418 AAGCACACAAACACTCTTTAACGAATTTTATAGTGAAAATATTTAT-
CCGTACGATGTACCTGACTATGCATATCCGTACGATGTTCCAGACTATGCTTGAGTGTAGGCTGGAGCTGCTTC
PipB2 chr 2-HA tag O-118 ATTGCTTTTATTTCAGATTTACGTCAAAAAGGGCCATATGAATATCCTCCTTAG
SopD2 PCR check mutagenesis, O-126 GCGCCTGGCGTCGCATTC
SopD2 PCR check mutagenesis, O-127 CTCGTACCTTCACGCAGACC
PipB2 PCR check mutagenesis, O-143 CGTAAAGGGGGTATTCACCTTATCTC
PipB2 PCR check mutagenesis, O-144 GGCACTTATACATCCAGGCATAGCG
doi:10.1371/journal.ppat.1001002.t004
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SCVs were labelled by using antibodies against the lysosomal
glycoprotein LAMP1. Infected cells were observed by epifluores-
cence, and the percentage of GFP-expressing bacteria present in a
vacuole was determined by counting the total number of bacteria
and the number of bacteria encircled by the LAMP1 marker. The
percentage of SCVs positive for LC3, P62, FK2 or kinesin-1 was
determined by visualizing GFP-expressing bacteria in the green
channel, LAMP1 in the UV channel (using Alexa Fluor 350
secondary antibodies), and LC3, P62, FK2 or kinesin HC in the
red channel. The percentage of bacteria expressing DsRed upon
induction with arabinose was enumerated by visualizing DsRed-
expression in the red channel, Salmonella LPS in the UV channel,
and LC3, P62 or FK2 in the green channel. The percentage of
infected cells containing LAMP1-tubules, PipB2-2HA- or SseJ-
2HA-positive tubules was determined by counting the total
number of infected cells and the number of infected cells
containing the respective tubule stained. The scorings for each
experiment were at least performed three times. All statistical
analyses were performed by using InStat (GraphPad). The two-
tailed P value was calculated.
Quantitative analysis of confocal images
Detector settings were optimized to match PMT gain and offset
to the most and the less fluorescent area of coverslips, respectively.
For each experiment these settings were not changed. Two colour
images of GFP-Salmonella (green)-infected HeLa cells immunola-
beled for kinesin heavy chain (red) were recorded. Individual
Salmonella-containing vacuoles (SCVs) were analyzed using Zeiss
LSM510 software as follows. The kinesin-1 enrichment was
defined as the mean fluorescence of the SCV minus the mean
fluorescence of an identical adjacent cellular area. The relative
amount of kinesin heavy chain enrichment of each SCV was
plotted for the sifA
2 and sifA
2sopD2
2 SCVs.
Processing for conventional electron microscopy and
scoring
Cells were fixed for 1 h at room temperature with 2.5%
glutaraldehyde (Sigma) in 0.1 M cacodylate buffer, pH 7.2,
containing 0.1 M sucrose, 5 mM CaCl2 and 5 mM MgCl2. Cells
were then washed twice with the same buffer and postfixed for 1 h
at room temperature with 1% osmium tetroxide (Electron
Microscopy Sciences) in the same buffer devoid of sucrose. Cells
were then scraped off the dishes and concentrated in 2% agar in
the same buffer and treated for 1 h at room temperature with 1%
uranyl acetate in Veronal buffer. Samples were dehydrated in a
graded series of acetone and embedded in Epon resin. Thin
sections were stained with 2% uranyl acetate in distilled water and
then with lead citrate. 50 to 100 different vacuoles per sample, on
two different EM grids, were scored as being within normal SCVs,
phagolysosomes, autophagic vacuoles or within the cytosol. Care
was taken to avoid serial sections.
Mouse mixed infections
Six- to eight-week-old C57BL/6 mice were inoculated intra-
peritoneally with equal amounts of two bacterial strains for a total
of 10
5 bacteria per mouse. The spleens were harvested 48 h after
inoculation and homogenized. Bacteria were recovered and
enumerated after plating a dilution series onto LB agar and LB
agar with the appropriate antibiotics. CIs were determined for
each mouse [29] and a minimum of three mice were infected. The
CI is defined as the ratio between the mutant and wild type strains
within the output (bacteria recovered from the mouse after
infection) divided by their ratios within the input (initial inoculum).
Unpaired t-test analysis was performed to compare two CIs, and a
one-sample t-test comparing the log of the CI to 0 was used to
determine whether the CI was significantly different from 1. All
statistical analyses were performed using Prism (GraphPad).
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